Concepedia

Jack A. Roth

JA

Statistics

Publications

20

Citations

2.2K

H-Index

19

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

NewGen Therapeutics (United States)

Molecular Oncology (United States)

The University of Texas Southwestern Medical Center

Jack A. Roth is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and molecular biology.

ORCID

Publications per year

1991–2020

20

Publications

20

Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.

T. Fujiwara, Elizabeth A. Grimm, Tapas Mukhopadhyay et al. · PubMed · 1994 · 468 citations

, , +17

p53 gene mutations in Barrett's epithelium and esophageal cancer.

Alan G. Casson, Tapas Mukhopadhyay, Karen R. Cleary et al. · PubMed · 1991 · 265 citations

, , +12

Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

Liang Ji, B Fang, Nancy Yen et al. · PubMed · 1999 · 244 citations

, , +13

Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene Therapy

Abner M. Mhashilkar, Robert D. Schrock, M. Hindi et al. · Molecular Medicine · 2001 · 162 citations · Full text

, , +17

Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo

Jieru Meng, Bingbing Dai, Bingliang Fang et al. · PLoS ONE · 2010 · 146 citations · Full text

, , +15

1–5 of 20